Research and Development

The Research and Development team at Capsida Biotherapeutics is focused on advancing innovative therapies for monogenetic and sporadic CNS and non-CNS disorders. This multidisciplinary group, comprising experts in automation, assay development, and quantitative biology, collaborates to design, optimize, and validate new biotherapeutics, leveraging cutting-edge technologies to drive discoveries from the lab to clinical applications.